Diff of /data/DLBCL_overview.txt [000000] .. [28aa3b]

Switch to side-by-side view

--- a
+++ b/data/DLBCL_overview.txt
@@ -0,0 +1,11 @@
+"GSE" "Study" "FullName" "Author" "ArrayTypes" "Citation"
+"1" "GSE56315" "CHEPRETRO" "CHEPRETRO" "Dybkaer et. al." "hgu133plus2" "Dybkaer K, Boegsted M, Falgreen S, Boedker JS et al. Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis. J Clin Oncol 2015 Apr 20;33(12):1379-88. PMID: 25800755"
+"2" "GSE19246" "BCCA" "British Columbia Cancer Agency" "Williams et. al." "hgu133plus2" "Williams PM, Li R, Johnson NA, Wright G et al. A novel method of amplification of FFPET-derived RNA enables accurate disease classification with microarrays. J Mol Diagn 2010 Sep;12(5):680-6. PMID: 20688907"
+"3" "GSE12195" "CUICG" "Columbia University, Institute for Cancer Genetics" "Pasqualucci et. al." "hgu133plus2" "Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011 Mar 10;471(7337):189-95. PMID: 21390126"
+"4" "GSE22895" "HMRC" "Hematologic Malignancies Research Consortium" "Jima et. al." "hugene10st" "Jima DD, Zhang J, Jacobs C, Richards KL et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood 2010 Dec 2;116(23):e118-27. PMID: 20733160"
+"5" "GSE31312" "IDRC" "International DLBCL Rituximap Consortium, MD Anderson Project" "Visco et. al." "hgu133plus2" "Visco C, Li Y, Xu-Monette ZY, Miranda RN et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 2012 Sep;26(9):2103-13. PMID: 22437443"
+"6" "GSE10846" "LLMPP" "Lymphoma/Leukemia Molecular Profiling Project" "Lenz et. al." "hgu133plus2" "Lenz G, Wright G, Dave SS, Xiao W et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008 Nov 27;359(22):2313-23. PMID: 19038878"
+"7" "GSE34171" "MDFCI" "Mayo-Dana-Farber Cancer Institute" "Monti et. al." "hgu133plus2,hgu133a,hgu133b,snp6" "Monti S, Chapuy B, Takeyama K, Rodig SJ et al. Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell 2012 Sep 11;22(3):359-72. PMID: 22975378"
+"8" "GSE22470" "MMML" "Molecular Mecahnisms in Malignant Lymphoma project" "Richter et. al." "hgu133a" "Richter J, Schlesner M, Hoffmann S, Kreuz M et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 2012 Dec;44(12):1316-20. PMID: 23143595"
+"9" "GSE4475" "UBCBF" "Universitaetsmedizin Berlin, Campus Benjamin Franklin" "Hummel et. al." "hgu133a" "Hummel M, Bentink S, Berger H, Klapper W et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006 Jun 8;354(23):2419-30. PMID: 16760442"
+"10" "GSE11318" "NCI" "National Cancer Institute" "Lenz. et. al." "hgu133plus2" "Lenz G, Wright GW, Emre NC, Kohlhammer H et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A 2008 Sep 9;105(36):13520-5. PMID: 18765795"